Oncolytics Biotech, Inc. (ONCY)
0.88
-0.02
(-2.22%)
USD |
NASDAQ |
May 08, 12:50
Oncolytics Biotech Research and Development Expense (Annual) : 13.31M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Karyopharm Therapeutics, Inc. | 125.32M |
| Sensei Biotherapeutics, Inc. | 10.96M |
| Candel Therapeutics, Inc. | 29.65M |
| Tango Therapeutics, Inc. | 129.88M |
| Moderna, Inc. | 2.917B |